Education
About Us
Working with TipRanks
Follow Us
Glenmark Life Sciences Limited (IN:GLS)
:GLS
GLS Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹820.05 - ₹1,335.00
Previous CloseN/A
Volume27.91K
Average Volume (3M)4.28K
Market Cap
₹125.60B
Enterprise ValueN/A
Total Cash (Recent Filing)₹3.02B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)25.5
Beta0.76
Next Earnings
Aug 08, 2025EPS EstimateN/A
Last Dividend Ex-Date
Oct 17, 2023Dividend Yield3.96%
Share Statistics
EPS (TTM)11.35
Shares Outstanding122,629,150
10 Day Avg. Volume4,038
30 Day Avg. Volume4,279
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GLS FAQ
What was Glenmark Life Sciences Limited’s price range in the past 12 months?
Glenmark Life Sciences Limited lowest stock price was ₹820.05 and its highest was ₹1335.00 in the past 12 months.
What is Glenmark Life Sciences Limited’s market cap?
Glenmark Life Sciences Limited’s market cap is ₹125.60B.
When is Glenmark Life Sciences Limited’s upcoming earnings report date?
Glenmark Life Sciences Limited’s upcoming earnings report date is Aug 08, 2025 which is in 62 days.
How were Glenmark Life Sciences Limited’s earnings last quarter?
Glenmark Life Sciences Limited released its earnings results on May 15, 2025. The company reported ₹11.35 earnings per share for the quarter, beating the consensus estimate of ₹10.2 by ₹1.15.
Is Glenmark Life Sciences Limited overvalued?
According to Wall Street analysts Glenmark Life Sciences Limited’s price is currently Overvalued.
Does Glenmark Life Sciences Limited pay dividends?
Glenmark Life Sciences Limited pays a Annually dividend of ₹22.5 which represents an annual dividend yield of 3.96%. See more information on Glenmark Life Sciences Limited dividends here
What is Glenmark Life Sciences Limited’s EPS estimate?
Glenmark Life Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glenmark Life Sciences Limited have?
Glenmark Life Sciences Limited has 122,629,150 shares outstanding.
What happened to Glenmark Life Sciences Limited’s price movement after its last earnings report?
Glenmark Life Sciences Limited reported an EPS of ₹11.35 in its last earnings report, beating expectations of ₹10.2. Following the earnings report the stock price went up 2.168%.
Which hedge fund is a major shareholder of Glenmark Life Sciences Limited?
Currently, no hedge funds are holding shares in IN:GLS
Technical Analysis
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Divi's Laboratories Limited
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―